Moderna said it will seek US regulators’ approval in June (File)
Washington:
US biotech firm Moderna said Tuesday that trials had shown its Covid-19 vaccine is “highly effective” in adolescents aged 12-17 and the company would seek regulators’ approval in June.
“We are encouraged that mRNA-1273 was highly effective at preventing Covid-19 in adolescents,” CEO Stephane Bancel said in a statement.
“We will submit these results to the US FDA and regulators globally in early June and request authorization.”
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)